Real-World Data Of Cancer Drugs In Elderly Could Push Regulators Toward Broader Trial Eligibility

 
• By Sarah Karlin-Smith
  
senior citizens playing cards
Real-world evidence shows older patients not getting trial-level benefits of cancer drugs. • Source: DCPhoto / Alamy Stock Photo
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials